AfroCAB

HIV treatment advocates network
Skip to content
  • Home
  • About
  • Meetings
  • Forums
  • Members
  • Resources
  • Join
  • Contact

AfroCAB documents and policies

  • Administration
  • Appeals and complaints
  • BHIVA guideline writing groups – background
  • Community representation
  • Copyright policy
  • Governance
  • Meeting organisation
  • Membership terms
  • Message board user agreement
  • UK-CAB representation at pharmaceutical company CABs
  • Wesbite privacy policy
  • Website disclaimer
Published: September 27, 2010
Last edited: August 9, 2016
  • Membership of AfroCAB is free and open to HIV-positive people and community advocates.

  • Pages

    • Home
    • AfroCAB activities by country
    • AFROCAB members at INTEREST conference
    • @afrocab_hiv and #TAG are excited to share a call for a new cross-disease long-acting technologies (LAT) community advisory board (CAB) focused on #malaria, the #HepC virus and #LTBI for a 4year tenure, 2021-2024. Deadline 1st June 2021!
    • Board Members
    • AHD Graphics to share!
    • About AfroCAB
      • Membership terms
      • Executive Steering Committee (ESC)
      • Community representatives
      • AfroCAB documents and policies
        • Administration
        • Appeals
        • Guidelines writing groups - background
        • Copyright policy
        • Governance
        • Meeting organisation
        • Membership terms
        • AfroCAB message board user agreement and posting rules
        • AfroCAB representation at pharmaceutical company Community Advisory Boards
        • Community representation
        • Privacy policy
        • Disclaimer
      • Contact AfroCAB
      • AfroCAB Funders
      • Site map
      • Full Sitemap
    • Contact AfroCAB
    • Join the AfroCAB
    • Meetings
    • Resources
    • AfroCAB members
  • This is a peer-led network. Information on this website is provided as a guide only.
    • Privacy
    • Disclaimer
    • Contact
    • About
    • Sitemap
    • RSS feed
Copyright © 2023 AfroCAB.